Hutch News

Hutch News

Stories tagged 'Anna Wald'

Experimental herpes drug more effective than standard treatment

Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows

Dec. 20, 2016 | By Mary Engel / Fred Hutch News Service

The results of the phase 2, randomized, double-blind trial published today in JAMA showed that when people with genital herpes took a daily oral dose of pritelivir, they reduced their rate of viral shedding by half compared to when they took valacyclovir. They also had fewer genital sores and less pain.

View story >


Halting herpes' transmission

New Hutch study predicts threshold of viral load for passing herpes from one person to another

March 25, 2014 | By Mary Engel

Fred Hutch researchers used mathematical models to predict viral loads below which transmission of the herpes virus is unlikely to occur. Preventing transmission is critical because there is no cure for herpes.

View story >


Genital herpes can spread even when lesions aren't present

Largest study of herpes simplex virus type 2 to date finds asymptomatic carriers can transmit virus to partners

April 25, 2011

Persons who have tested positive for herpes simplex virus type 2 but do not have symptoms or genital lesions still experience virus shedding during subclinical episodes, suggesting a high risk of transmission from persons with unrecognized HSV-2 infection, according to a study in the April 13 issue of the Journal of the American Medical Association.

View story >


Riddell, Wald elected to Association of American Physicians

Honor recognizes contributions of physician-scientists

May 3, 2010

The Association of American Physicians recently added to its ranks Dr. Stanley Riddell, a Clinical Research Division immunologist and a University of Washington School of Medicine oncology professor, and Dr. Anna Wald, an attending physician at the Seattle Cancer Care Alliance and director of the UW’s Virology Research Clinic.

View story >


Proof in packaging

Virologist Anna Wald's research shows herpes risk cut in half for consistent condom users, lends substance to debate over labeling

Jan. 5, 2006 | By COLLEEN STEELQUIST

View story >


Stemming the spread of STD's

International center-led trial finds that a daily dose of an antiviral drug halves transmission of genital herpes, may lessen other STD infections

Jan. 8, 2004

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.